Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9636
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSevak, Kajol D-
dc.date.accessioned2021-01-27T06:30:00Z-
dc.date.available2021-01-27T06:30:00Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9636-
dc.description.abstractIn the world there are millions of people suffering from the HIV positive. There are various medications are available for the HIV, which includes the various antiretroviral treatment having the safety. Antiretroviral are given orally so also there is possibility of the drug interaction. Lipid carries used to solubilize the very poorly soluble drug. Lipids with the short chain, long chain medium chain were used as oil phase. The Atazavair is the class four drug having the very solubility so the purpose of this study is to check the solubility of the drug Atazanavir sulfate with the various lipids. This lipid carrier was formulated an evaluated with the particle size, zeta potential, drug loading. Materials and methods: - Various types of oils and surfactant, co-surfactant was used for the solubility study like capmul, transcutol, labrazol. The phase diagram was used for the study.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00601;-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceuticsen_US
dc.subject18MPHen_US
dc.subject18MPH105en_US
dc.subjectPDR00601-
dc.titleLipid-Based Nano-Delivery for Oral Administration of Atazanavir: Design, Optimization and Characterizationen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Department of Pharmaceutical Technology and Biopharmaceutics

Files in This Item:
File Description SizeFormat 
PDR00601.pdfPDR006013.62 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.